HopeStage
Back to all studies
CompletedNCT03015246

Buprenorphine/Naloxone Dose, Stress, and Opioid Use

About this titleRead the official source — NCT03015246
Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

What did participation involve?

The study compares medication regimens involving extended-release morphine or buprenorphine/naloxone. Within those groups, the protocol also compares a medication-induced stress procedure with a placebo (an inactive comparison treatment) procedure.

Listed locations
Overland ParkSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 2016
Recruitment status
Completed
Enrollment listed in the registry
26
Sponsor
Wayne State University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT03015246
Official title
Show the full official title

Biobehavioral Studies of Opioid Seeking: Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Overland Park

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did participation involve?

The protocol called for participants to take study medication.

Who is behind this study?

The study sponsor is Wayne State University, a university.

Did this study involve medication?

Yes. The study involved medication, including Extended release morphine, Buprenorphine/Naloxone low dose, Buprenorphine/Naloxone moderate dose, Buprenorphine/Naloxone high dose, Active stressor and Placebo stressor.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies